BRAF and cancer: In cancers where B-Raf is mutated, such as the BRAF V600E mutation, the kinase is constitutively active, resulting in continuous signaling through the MAPK pathway, contributing to tumorigenesis (Bharti et al., 2025[8]; Brady et al., 2014[11]).